CS
MGNX icon

Credit Suisse’s MacroGenics MGNX Stock Holding History

Credit Suisse’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$528K Buy
+35,864
New +$542K ﹤0.01% 2618
2023
Q1 		– Sell
-2
Closed -$13 – 3546
2022
Q4 		$13 Sell
2
-55,161
-100% -$303K ﹤0.01% 3703
2022
Q3 		$190K Buy
55,163
+352
+0.6% +$1.35K ﹤0.01% 3268
2022
Q2 		$161K Buy
54,811
+790
+1% +$4.15K ﹤0.01% 3407
2022
Q1 		$475K Buy
54,021
+5,149
+11% +$56.8K ﹤0.01% 3013
2021
Q4 		$784K Sell
48,872
-2,908
-6% -$54.7K ﹤0.01% 3504
2021
Q3 		$1.08M Buy
51,780
+2,535
+5% +$61.1K ﹤0.01% 3281
2021
Q2 		$1.32M Buy
49,245
+2,963
+6% +$86.8K ﹤0.01% 3173
2021
Q1 		$1.47M Sell
46,282
-48,656
-51% -$1.18M ﹤0.01% 3045
2020
Q4 		$2.17M Buy
94,938
+9,384
+11% +$216K ﹤0.01% 2759
2020
Q3 		$2.15M Buy
85,554
+25,106
+42% +$686K ﹤0.01% 2373
2020
Q2 		$1.69M Buy
60,448
+22,311
+59% +$388K ﹤0.01% 2516
2020
Q1 		$222K Sell
38,137
-5,428
-12% -$49.3K ﹤0.01% 3595
2019
Q4 		$474K Buy
43,565
+11,428
+36% +$113K ﹤0.01% 3600
2019
Q3 		$410K Buy
32,137
+5,876
+22% +$84.6K ﹤0.01% 3541
2019
Q2 		$445K Sell
26,261
-3,357
-11% -$57.7K ﹤0.01% 3474
2019
Q1 		$531K Buy
29,618
+3,950
+15% +$68.3K ﹤0.01% 3292
2018
Q4 		$326K Buy
25,668
+1,090
+4% +$18.3K ﹤0.01% 3478
2018
Q3 		$527K Sell
24,578
-9,308
-27% -$198K ﹤0.01% 3265
2018
Q2 		$699K Sell
33,886
-4,380
-11% -$98.7K ﹤0.01% 3257
2018
Q1 		$964K Buy
38,266
+2,524
+7% +$61.3K ﹤0.01% 2976
2017
Q4 		$678K Sell
35,742
-10,173
-22% -$190K ﹤0.01% 3259
2017
Q3 		$849K Buy
45,915
+18,892
+70% +$327K ﹤0.01% 3216
2017
Q2 		$473K Sell
27,023
-20,685
-43% -$395K ﹤0.01% 3187
2017
Q1 		$887K Sell
47,708
-11,486
-19% -$222K ﹤0.01% 2950
2016
Q4 		$1.21M Buy
59,194
+22,914
+63% +$577K ﹤0.01% 2870
2016
Q3 		$1.09M Buy
36,280
+3,801
+12% +$113K ﹤0.01% 2886
2016
Q2 		$876K Sell
32,479
-1,659
-5% -$37.4K ﹤0.01% 3045
2016
Q1 		$640K Buy
34,138
+12,831
+60% +$244K ﹤0.01% 3063
2015
Q4 		$661K Buy
21,307
+5,640
+36% +$171K ﹤0.01% 3158
2015
Q3 		$335K Sell
15,667
-43,133
-73% -$1.35M ﹤0.01% 3653
2015
Q2 		$2.23M Buy
58,800
+30,537
+108% +$1M ﹤0.01% 2469
2015
Q1 		$888K Buy
28,263
+1,449
+5% +$49.1K ﹤0.01% 3070
2014
Q4 		$940K Buy
26,814
+11,993
+81% +$299K ﹤0.01% 3184
2014
Q3 		$310K Sell
14,821
-11,095
-43% -$229K ﹤0.01% 3919
2014
Q2 		$563K Buy
25,916
+18,285
+240% +$384K ﹤0.01% 3749
2014
Q1 		$212K Buy
+7,631
New +$269K ﹤0.01% 4317

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Credit Suisse's MGNX Position: Q1 2024 in Review

Credit Suisse opened a new position in MacroGenics (MGNX) in Q1 2024: 35,864 shares worth $528K. The stake represents ﹤0.01% of the portfolio and ranks #2618 among its holdings. This is a return to the name: Credit Suisse previously reported a position in MGNX as recently as Q4 2022.

Credit Suisse first reported a position in MGNX in Q1 2014 and has held it in 37 quarters since. The position peaked at $2.23M in Q2 2015. 163 funds tracked by Wall St. Rank hold MGNX as of Q1 2024.

  • Credit Suisse held 35,864 shares of MacroGenics worth $528K as of Q1 2024.
  • MacroGenics was a new Credit Suisse position in Q1 2024.
  • MacroGenics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2618 holding.
  • Credit Suisse first reported a position in MacroGenics in Q1 2014 and has held it in 37 quarters since.
  • Credit Suisse's MacroGenics position peaked at $2.23M in Q2 2015.
  • 163 funds tracked by Wall St. Rank held MacroGenics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.